bemnifosbuvir (AT-527) - Atea Pharma
Daklinza (daclatasvir) - BMS
ruzasvir (MK-8408) - Atea Pharma
uprifosbuvir (IDX21437) - Merck (MSD)
Sovaldi (sofosbuvir) - Gilead
https://journals.lww.com/hep/fulltext/2023/10001/the_liver_meeting__boston,_massachusetts_nov.1.aspx
 
Xiao-Jian Zhou1; Gaetano Morelli2; Maureen Montrond3; Shannan Lynch3; Keith Pietropaolo3; Bruce Belanger3; Arantxa Horga3; Janet Hammond3; 1Atea Pharmaceuticals, Inc., Boston, MA, United States; 2Altasciences Clinical Research; 3Atea Pharmaceuticals, Inc.
 
Oct 12, 2023
 
Prev Next